Email your Premier & Health Minister

The email tool below makes it easy for you to support the pulmonary arterial hypertension (PAH) and scleroderma communities by contacting your Premier and Health Minister. Through the letter provided below, you can ask your provincial elected officials to take action to ensure that all patients living with PAH (including those with SSc-PAH), have publicly funded access to optimal treatment for their disease.

Please Note: This email tool has been updated to reflect the current status of access to Uptravi (selexipag) across Canada, and the current focus of our advocacy efforts. Those living in British Columbia or Nova Scotia can send a letter to the Premier, Health Minister and their Member of Legislative Assembly (MLA).

As of October 30, 2018, British Columbia has joined the vast majority of provinces to make Uptravi accessible through public funding for patients in need.

The following day, October 31, 2018, Nova Scotia also joined this growing list and Uptravi will be made accessible through public funding.

Please select British Columbia or Nova Scotia in the email tool below to send a thank you letter to the respective provincial governments for their support in ensuring that Uptravi is accessible through public funding for patients in need.

 

Once you have entered your name and email address in the form below and have selected your letter recipient, you may send the letter as-is or customize it. You may add as much detail as you wish and, if applicable, we encourage you to include details of how PAH or SSc-PAH, has personally impacted your life.

The Pulmonary Hypertension Association of Canada (PHA Canada) and Scleroderma Canada (SC) truly appreciates your support.

If you are located in Quebec and French is your preferred language, please click here.

For more information about our advocacy efforts, including the current campaign for access to Uptravi, please click here.

Privacy Policy

PHA Canada and SC respect the privacy of each individual who uses this website. The limited identifiable personal information collected through this website (i.e. email addresses) will never be used or released by either organization without the written permission of the individual.

Email Tool